#MILLIPORE SIGMA ALDRICH FULL#

Shaped over almost 350 years by a family of owners, Merck KGaA, Darmstadt, Germany, today is known as a successful and values-driven business and a well-respected employer in the life science industry.

In pharma and biopharma production, Sigma-Aldrich will complement EMD Millipore’s existing products and capabilities with additions along the entire value chain of drug production and validation. In the Laboratory & Academia business, together EMD Millipore and Sigma-Aldrich will offer their customers a complementary range of products across laboratory chemicals, biologics and reagents. The combined company will be able to serve life science customers around the world with a highly attractive set of established brands and an efficient supply chain that can support the delivery of more than 300,000 products. We believe this is a very positive outcome for our shareholders, who will receive a significant premium, and our employees, who will benefit from enhanced opportunities as part of a larger, more global organization.” This is a testament to the strength of the Sigma-Aldrich brand and the accomplishments of our 9,000 employees worldwide. This transaction is a clear validation of our success in transforming Sigma-Aldrich into a customer-focused and solutions-oriented global organization. The combined company will be well-positioned to deliver significant customer benefits, including a broader, complementary range of products and capabilities, greater investment in breakthrough innovations, enhanced customer service, and a leading e-commerce and distribution platform in the industry. Rakesh Sachdev, President and Chief Executive Officer of Sigma-Aldrich, said, “We are excited to join forces with Merck KGaA, Darmstadt, Germany, a distinguished industry leader.

#MILLIPORE SIGMA ALDRICH FULL#

We are delighted to make this compelling proposition to Sigma-Aldrich’s shareholders, who will obtain full and certain cash value for their shares.” What’s more, the combination gives us the possibility to invest even more in innovation going forward. As such, the combination of Merck KGaA, Darmstadt, Germany and Sigma-Aldrich will secure stable growth and profitability in an industry that is driven by trends such as the globalization of research and manufacturing. In one of the world’s key industries two companies that fit perfectly together have found each other to present a much broader product offering to our global customers in research, pharma and biopharma manufacturing and diagnostic and testing labs. “For our life science business it’s even more than that: it’s a quantum leap. “This transaction marks a milestone on our transformation journey aimed at turning our three businesses into sustainable growth platforms”, said Karl-Ludwig Kley, Chairman of Merck KGaA, Darmstadt, Germany’s Executive Board. Merck KGaA, Darmstadt, Germany expects to achieve annual synergies of approximately €260 million (approximately $340 million), which should be fully realized within three years after closing. The transaction is expected to be immediately accretive to Merck KGaA, Darmstadt, Germany's EPS pre and EBITDA margin. The agreed price represents a 37% premium to the latest closing price of $102.37 on September 19, 2014, and a 36% premium to the one-month average closing price. Merck KGaA, Darmstadt, Germany, will acquire all of the outstanding shares of Sigma-Aldrich for $140 per share in cash. Louis, MO - Merck KGaA, Darmstadt, Germany, a leading company for innovative and top-quality high-tech products in the pharmaceutical, chemical and life science sectors, and Sigma-Aldrich today announced that they have entered into a definitive agreement under which Merck KGaA, Darmstadt, Germany, will acquire Sigma-Aldrich for $17.0 billion (€13.1 billion), establishing one of the leading players in the $130 billion global life science industry. September 22, 2014, Darmstadt, Germany and St. Merck KGaA, Darmstadt, Germany, to host media conference call today at 8:00 AM EDT / 2:00 PM CET.

Transaction expected to be immediately accretive to EPS pre and EBITDA margin.Life Science contribution to Merck KGaA, Darmstadt, Germany, earnings more than doubles.Merck KGaA, Darmstadt, Germany, plans to maintain significant presence in St.Customers benefit from broader offering of complementary products and capabilities and leading e-commerce platform in the industry.Acquisition expands EMD Millipore’s global reach, increasing the company’s presence in North America and adding exposure to fast-growing Asian markets.Merck KGaA, Darmstadt, Germany, to acquire Sigma-Aldrich for $140 per share in cash, valuing company at approx.Merck KGaA, Darmstadt, Germany, to Acquire Sigma-Aldrich to Enhance Position in Attractive Life Science Industry

Millipore sigma aldrich